Cibc World Markets Corp lifted its holdings in Centene Co. (NYSE:CNC – Free Report) by 12.2% during the 4th quarter, Holdings Channel reports. The fund owned 80,627 shares of the company’s stock after acquiring an additional 8,787 shares during the quarter. Cibc World Markets Corp’s holdings in Centene were worth $4,884,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also modified their holdings of the business. Stratos Wealth Partners LTD. boosted its holdings in shares of Centene by 4.1% in the 4th quarter. Stratos Wealth Partners LTD. now owns 4,094 shares of the company’s stock worth $248,000 after acquiring an additional 163 shares in the last quarter. Capital Advisors Ltd. LLC lifted its holdings in Centene by 75.3% during the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock worth $25,000 after buying an additional 177 shares in the last quarter. Private Trust Co. NA lifted its holdings in Centene by 23.7% during the 4th quarter. Private Trust Co. NA now owns 956 shares of the company’s stock worth $58,000 after buying an additional 183 shares in the last quarter. Howard Capital Management Inc. lifted its holdings in Centene by 5.4% during the 4th quarter. Howard Capital Management Inc. now owns 3,591 shares of the company’s stock worth $218,000 after buying an additional 184 shares in the last quarter. Finally, Intellectus Partners LLC lifted its holdings in Centene by 2.8% during the 4th quarter. Intellectus Partners LLC now owns 7,224 shares of the company’s stock worth $438,000 after buying an additional 200 shares in the last quarter. 93.63% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several research analysts have issued reports on the company. Jefferies Financial Group downgraded Centene from a “hold” rating to an “underperform” rating and reduced their price objective for the stock from $68.00 to $52.00 in a report on Tuesday, December 10th. Robert W. Baird upped their price objective on Centene from $66.00 to $71.00 in a report on Tuesday, February 4th. Barclays upped their target price on shares of Centene from $91.00 to $93.00 and gave the company an “overweight” rating in a research report on Friday, December 13th. StockNews.com cut shares of Centene from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 6th. Finally, Argus cut shares of Centene from a “buy” rating to a “hold” rating in a research report on Thursday, February 6th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Centene presently has an average rating of “Moderate Buy” and a consensus target price of $79.92.
Centene Trading Down 0.7 %
Centene stock opened at $59.26 on Thursday. Centene Co. has a 52 week low of $55.03 and a 52 week high of $80.59. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.10 and a current ratio of 1.11. The stock has a market capitalization of $29.40 billion, a P/E ratio of 9.50, a PEG ratio of 0.80 and a beta of 0.40. The stock has a 50-day simple moving average of $60.39 and a 200 day simple moving average of $63.43.
Centene (NYSE:CNC – Get Free Report) last posted its quarterly earnings results on Tuesday, February 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.49 by $0.31. Centene had a return on equity of 13.85% and a net margin of 2.03%. The business had revenue of $40.81 billion during the quarter, compared to analysts’ expectations of $38.78 billion. During the same quarter last year, the company posted $0.45 earnings per share. Centene’s quarterly revenue was up 3.4% on a year-over-year basis. Analysts expect that Centene Co. will post 6.86 earnings per share for the current year.
Centene Company Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Read More
- Five stocks we like better than Centene
- Investing In Automotive Stocks
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- 3 Best Fintech Stocks for a Portfolio Boost
- Alphabet’s Officially In A Bear Market—Time To Buy?
- What is a Low P/E Ratio and What Does it Tell Investors?
- D-Wave and Quantum Supremacy: Implications For Investors
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.